Topic Archives:
ERIC Alert: New Prescription Drug Law Could Raise Costs and Limit Access for Arkansas Workers and Families
Washington, D.C., April 29, 2025 – This month, Arkansas Governor Sarah Huckabee Sanders signed into law HB 1150, a bill that prohibits any and all pharmacies owned by or affiliated with a pharmacy benefit manager (“PBM”) from receiving a permit for the retail sale of drugs or medicines in Arkansas.
ERIC Health Care Policy Highlights: EO on Lowering Prescription Drug Prices; RFI on Deregulation; and More
ERIC Health Care Policy Highlights: Ways and Means Biosimilars Focus; Democrats’ December Package Position; and More!
ERIC Health Care Policy Highlights: 2025 Policy Priorities; Victory! McKee Case; and More
ERISA Victory: ERIC Applauds Court Ruling Upholding Employers’ Rights to Design Employee Benefit Plans
Washington, D.C., April 2, 2025 – On Monday, the U.S. District Court for the Eastern District of Tennessee granted a motion for summary judgment in McKee Foods Corporation v. BFP, Inc. The court agreed with McKee Foods that the Employee Retirement Income Security Act preempts key provisions of Tennessee’s law requiring that employers include “any willing pharmacy” in the networks maintained by the pharmacy benefit plans employers sponsor for workers and their families.
ERIC Health Care Policy Highlights: MHP Lawsuit Update; CMS IDR 2024 Q1 & Q2 Data; and More
ERIC Health Care Policy Highlights: Nominations Update; WV PBM Law; and More
ERIC Cautions Texas Health Care Legislation Raises ERISA Preemption Concerns
Washington, D.C., March 10, 2025 – The ERISA Industry Committee (ERIC) last week wrote to Chair Kolkhorst and Members of the Texas Senate Committee on Health and Human Services expressing concerns that state policies, such as those proposed by SB 1122, would interfere with the design and administration of self-funded health benefit plans governed by the federal Employee Retirement Income Security Act of 1974 (“ERISA”). Given the rising cost of prescription drugs and the growing interest in regulating pharmacy benefit managers (PBMs), ERIC urged the Committee to address the ERISA preemption issues raised by SB 1122 to avoid legal challenges seen in other states. An ERIC statement can be found below and is attributable to Dillon Clair, Director of State Advocacy for ERIC.